Literature DB >> 23195333

Sulforaphane induces SLPI secretion in the nasal mucosa.

Megan Meyer1, Matthew J Kesic, John Clarke, Emily Ho, Rosalia C M Simmen, David Diaz-Sanchez, Terry L Noah, Ilona Jaspers.   

Abstract

Cells lining the respiratory tract are equipped with mechanisms that dampen the effects of oxidative stress. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a mediator involved in regulating oxidative stress. Recent data indicate Nrf2 also controls expression of secretory leukocyte protease inhibitor (SLPI). Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, enhances Nrf2 activity. Therefore, we hypothesized that SFN supplementation induces SLPI secretion in the nasal mucosa in an Nrf2 dependent manner. Healthy nonsmoking adults ingested SFN-containing broccoli shake homogenate (BSH) for 3 consecutive days. Nasal lavage fluid (NLF) was collected before and after BSH ingestion and analyzed for SLPI protein levels. In follow up in vitro experiments, differentiated primary nasal epithelial cells were used to evaluate the relationship between SFN, Nrf2, and SLPI. Epithelial cells were transduced with Nrf2-specific shRNA to examine the regulatory role of Nrf2 on SLPI expression. Supplementation with BSH significantly increased SLPI levels in NLF. SFN supplementation in vitro significantly enhanced SLPI secretion and these effects were significantly decreased in cells transduced with Nrf2-specific shRNA. Our data support a relationship between nutritional supplementation, Nrf2 activation, and SLPI secretion. Therefore, ingestion of SFN-containing foods has therapeutic potential to augment SLPI expression in the nasal mucosa.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23195333      PMCID: PMC3640824          DOI: 10.1016/j.rmed.2012.11.006

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  10 in total

Review 1.  SLPI and elafin: multifunctional antiproteases of the WFDC family.

Authors:  Aaron Scott; Sinéad Weldon; Clifford C Taggart
Journal:  Biochem Soc Trans       Date:  2011-10       Impact factor: 5.407

Review 2.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Authors:  Thomas W Kensler; Nobunao Wakabayashi; Shyam Biswal
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema.

Authors:  Takashi Iizuka; Yukio Ishii; Ken Itoh; Takumi Kiwamoto; Toru Kimura; Yosuke Matsuno; Yuko Morishima; Ahmed E Hegab; Shinsuke Homma; Akihiro Nomura; Tohru Sakamoto; Masako Shimura; Aruto Yoshida; Masayuki Yamamoto; Kiyohisa Sekizawa
Journal:  Genes Cells       Date:  2005-12       Impact factor: 1.891

4.  Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema.

Authors:  Yukio Ishii; Ken Itoh; Yuko Morishima; Toru Kimura; Takumi Kiwamoto; Takashi Iizuka; Ahmed E Hegab; Tomonori Hosoya; Akihiro Nomura; Tohru Sakamoto; Masayuki Yamamoto; Kiyohisa Sekizawa
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

5.  Comparison of isothiocyanate metabolite levels and histone deacetylase activity in human subjects consuming broccoli sprouts or broccoli supplement.

Authors:  John D Clarke; Ken Riedl; Deborah Bella; Steven J Schwartz; Jan F Stevens; Emily Ho
Journal:  J Agric Food Chem       Date:  2011-09-30       Impact factor: 5.279

6.  Sulforaphane-stimulated phase II enzyme induction inhibits cytokine production by airway epithelial cells stimulated with diesel extract.

Authors:  Stacey A Ritz; Junxiang Wan; David Diaz-Sanchez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-11       Impact factor: 5.464

7.  Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway.

Authors:  Marc A Riedl; Andrew Saxon; David Diaz-Sanchez
Journal:  Clin Immunol       Date:  2008-11-22       Impact factor: 3.969

8.  Tobacco smoke exposure and altered nasal responses to live attenuated influenza virus.

Authors:  Terry L Noah; Haibo Zhou; Jane Monaco; Katie Horvath; Margaret Herbst; Ilona Jaspers
Journal:  Environ Health Perspect       Date:  2010-10-04       Impact factor: 9.031

9.  Nrf2 expression modifies influenza A entry and replication in nasal epithelial cells.

Authors:  Matthew J Kesic; Steven O Simmons; Rebecca Bauer; Ilona Jaspers
Journal:  Free Radic Biol Med       Date:  2011-04-19       Impact factor: 7.376

10.  Exposure to ozone modulates human airway protease/antiprotease balance contributing to increased influenza A infection.

Authors:  Matthew J Kesic; Megan Meyer; Rebecca Bauer; Ilona Jaspers
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

  10 in total
  14 in total

Review 1.  Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants.

Authors:  Megan Meyer; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-04-17       Impact factor: 5.464

2.  Regulation and activity of secretory leukoprotease inhibitor (SLPI) is altered in smokers.

Authors:  Megan Meyer; Rebecca N Bauer; Blanche D Letang; Luisa Brighton; Elizabeth Thompson; Rosalia C M Simmen; James Bonner; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-27       Impact factor: 5.464

3.  E-cigarette use results in suppression of immune and inflammatory-response genes in nasal epithelial cells similar to cigarette smoke.

Authors:  Elizabeth M Martin; Phillip W Clapp; Meghan E Rebuli; Erica A Pawlak; Ellen Glista-Baker; Neal L Benowitz; Rebecca C Fry; Ilona Jaspers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-06-10       Impact factor: 5.464

4.  Genetic activation of Nrf2 reduces cutaneous symptoms in a murine model of Netherton syndrome.

Authors:  Sukalp Muzumdar; Michael Koch; Hayley Hiebert; Andreas Bapst; Alessia Gravina; Wilhelm Bloch; Hans-Dietmar Beer; Sabine Werner; Matthias Schäfer
Journal:  Dis Model Mech       Date:  2020-06-01       Impact factor: 5.758

Review 5.  Broccoli or Sulforaphane: Is It the Source or Dose That Matters?

Authors:  Yoko Yagishita; Jed W Fahey; Albena T Dinkova-Kostova; Thomas W Kensler
Journal:  Molecules       Date:  2019-10-06       Impact factor: 4.411

6.  Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease.

Authors:  Jennifer F Doss; Jude C Jonassaint; Melanie E Garrett; Allison E Ashley-Koch; Marilyn J Telen; Jen-Tsan Chi
Journal:  PLoS One       Date:  2016-04-12       Impact factor: 3.240

7.  Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice.

Authors:  Zheng Xu; Shudong Wang; Honglei Ji; Zhiguo Zhang; Jing Chen; Yi Tan; Kupper Wintergerst; Yang Zheng; Jian Sun; Lu Cai
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

8.  Effect of Broccoli Sprouts and Live Attenuated Influenza Virus on Peripheral Blood Natural Killer Cells: A Randomized, Double-Blind Study.

Authors:  Loretta Müller; Megan Meyer; Rebecca N Bauer; Haibo Zhou; Hongtao Zhang; Shannon Jones; Carole Robinette; Terry L Noah; Ilona Jaspers
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

Review 9.  Augmentation of Cationic Antimicrobial Peptide Production with Histone Deacetylase Inhibitors as a Novel Epigenetic Therapy for Bacterial Infections.

Authors:  Roshan D Yedery; Ann E Jerse
Journal:  Antibiotics (Basel)       Date:  2015-01-12

10.  KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane.

Authors:  Albena T Dinkova-Kostova; Jed W Fahey; Rumen V Kostov; Thomas W Kensler
Journal:  Trends Food Sci Technol       Date:  2017-02-16       Impact factor: 12.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.